![]()
22.10.20151552
Numerous studies have been conducted in many countries to identify the factors associated with readmission of patients with heart failure (HF).
![]()
21.10.20151610
Perioperative treatment with a beta-blocker may be linked to elevated risk for major adverse CV events and all-cause mortality in patients with uncomplicated hypertension undergoing noncardiac surgery, according to recent findings.
![]()
20.10.20151535
Young women with acute MI are less likely than young men to use secondary prevention CV medications, according to study findings published in Circulation: Cardiovascular Quality and Outcomes.
![]()
19.10.20151794
The 2013 American College of Cardiology/American Heart Association guidelines introduced the 10-year atherosclerotic CVD risk estimator to guide clinician–patient risk discussions about statin therapy.
![]()
15.10.20151608
Treatment with ranolazine did not lower rates of ischemia-driven revascularization or hospitalization without revascularization in patients with a history of chronic angina who had incomplete revascularization after PCI, according to late-breaking clinical trial results presented at the annual TCT Scientific Symposium.
![]()
13.10.20151525
Utilization of lipid-lowering agents has been associated with improved long-term outcomes in acute coronary syndrome (ACS) patients. However, updated data regarding local use and outcomes was lacking.
![]()
12.10.20151810
Do rate-control medications affect survival in patients with atrial fibrillation (AF)?
